About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
WASHINGTON, D.C. (March 16, 2022) – The Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President of Public Affairs Debra DeShong released the following statement after the Senate Finance Committee’s hearing on drug pricing:
“Today’s hearing demonstrated that many lawmakers aren’t serious about taking on the bipartisan work necessary to address the real challenges patients experience at the pharmacy. Government price setting won’t address the abusive insurance practices that put barriers between patients and the medicines they need, but it will jeopardize access to medicines and future innovation. The government’s own data show prescription medicines are not fueling inflation. If lawmakers continue to misdiagnose the problem, they won’t prescribe the kind of meaningful solutions patients need. Let’s focus on areas where there is broad agreement, like capping what seniors have to pay for medicines, and begin to deliver real relief for American patients.”
Press Release
Cost and Value
PhRMA Statement on the Senate Finance Committee Hearing on Drug Pricing
PhRMA Statement on the Senate Finance Committee Hearing on Drug Pricing image